Logo image of ALGTR.PA

GROUPE TERA (ALGTR.PA) Stock Fundamental Analysis

EPA:ALGTR - Euronext Paris - Matif - FR0013429404 - Common Stock - Currency: EUR

3.12  0 (0%)

Fundamental Rating

3

Overall ALGTR gets a fundamental rating of 3 out of 10. We evaluated ALGTR against 49 industry peers in the Electronic Equipment, Instruments & Components industry. While ALGTR seems to be doing ok healthwise, there are quite some concerns on its profitability. ALGTR has a correct valuation and a medium growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALGTR had negative earnings in the past year.
In the past year ALGTR had a positive cash flow from operations.
In the past 5 years ALGTR reported 4 times negative net income.
In the past 5 years ALGTR always reported negative operating cash flow.
ALGTR.PA Yearly Net Income VS EBIT VS OCF VS FCFALGTR.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 0 1M -1M -2M

1.2 Ratios

ALGTR has a Return On Assets of -4.88%. This is in the lower half of the industry: ALGTR underperforms 73.47% of its industry peers.
Looking at the Return On Equity, with a value of -39.96%, ALGTR is doing worse than 79.59% of the companies in the same industry.
Industry RankSector Rank
ROA -4.88%
ROE -39.96%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ALGTR.PA Yearly ROA, ROE, ROICALGTR.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 0 20 -20 40 60

1.3 Margins

With an excellent Gross Margin value of 82.33%, ALGTR belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
In the last couple of years the Gross Margin of ALGTR has declined.
ALGTR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.33%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.02%
GM growth 5Y-3.92%
ALGTR.PA Yearly Profit, Operating, Gross MarginsALGTR.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 0 20 40 60 80

More info and screens

4

2. Health

2.1 Basic Checks

ALGTR does not have a ROIC to compare to the WACC, probably because it is not profitable.
There is no outstanding debt for ALGTR. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ALGTR.PA Yearly Shares OutstandingALGTR.PA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 1M 2M 3M
ALGTR.PA Yearly Total Debt VS Total AssetsALGTR.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 5M 10M 15M

2.2 Solvency

ALGTR has an Altman-Z score of 1.07. This is a bad value and indicates that ALGTR is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of ALGTR (1.07) is worse than 81.63% of its industry peers.
The Debt to FCF ratio of ALGTR is 8.70, which is on the high side as it means it would take ALGTR, 8.70 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 8.70, ALGTR is in line with its industry, outperforming 55.10% of the companies in the same industry.
A Debt/Equity ratio of 4.52 is on the high side and indicates that ALGTR has dependencies on debt financing.
With a Debt to Equity ratio value of 4.52, ALGTR is not doing good in the industry: 89.80% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 4.52
Debt/FCF 8.7
Altman-Z 1.07
ROIC/WACCN/A
WACC6.94%
ALGTR.PA Yearly LT Debt VS Equity VS FCFALGTR.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 0 2M -2M 4M 6M

2.3 Liquidity

ALGTR has a Current Ratio of 2.28. This indicates that ALGTR is financially healthy and has no problem in meeting its short term obligations.
ALGTR has a Current ratio of 2.28. This is in the better half of the industry: ALGTR outperforms 73.47% of its industry peers.
A Quick Ratio of 2.12 indicates that ALGTR has no problem at all paying its short term obligations.
ALGTR has a better Quick ratio (2.12) than 87.76% of its industry peers.
Industry RankSector Rank
Current Ratio 2.28
Quick Ratio 2.12
ALGTR.PA Yearly Current Assets VS Current LiabilitesALGTR.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2M 4M 6M 8M 10M

More info and screens

6

3. Growth

3.1 Past

ALGTR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 12.41%, which is quite good.
The Revenue for ALGTR has decreased by -14.10% in the past year. This is quite bad
ALGTR shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.80% yearly.
EPS 1Y (TTM)12.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.68%
Revenue 1Y (TTM)-14.1%
Revenue growth 3Y26.49%
Revenue growth 5Y23.8%
Sales Q2Q%-9.38%

3.2 Future

ALGTR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 63.58% yearly.
Based on estimates for the next years, ALGTR will show a very strong growth in Revenue. The Revenue will grow by 22.33% on average per year.
EPS Next Y97.22%
EPS Next 2Y74.8%
EPS Next 3Y63.58%
EPS Next 5YN/A
Revenue Next Year30.53%
Revenue Next 2Y24.18%
Revenue Next 3Y22.33%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
ALGTR.PA Yearly Revenue VS EstimatesALGTR.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 5M 10M 15M 20M
ALGTR.PA Yearly EPS VS EstimatesALGTR.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 0.2 -0.2 0.4 0.6 0.8

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

ALGTR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
The Price/Forward Earnings ratio is 7.97, which indicates a rather cheap valuation of ALGTR.
81.63% of the companies in the same industry are more expensive than ALGTR, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.10. ALGTR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 7.97
ALGTR.PA Price Earnings VS Forward Price EarningsALGTR.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30 40

4.2 Price Multiples

ALGTR's Enterprise Value to EBITDA ratio is a bit more expensive when compared to the industry. ALGTR is more expensive than 63.27% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ALGTR is valued a bit cheaper than the industry average as 69.39% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 10.26
EV/EBITDA 28.08
ALGTR.PA Per share dataALGTR.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ALGTR's earnings are expected to grow with 63.58% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y74.8%
EPS Next 3Y63.58%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALGTR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

GROUPE TERA

EPA:ALGTR (3/6/2025, 7:00:00 PM)

3.12

0 (0%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners1.17%
Inst Owner ChangeN/A
Ins Owners7.36%
Ins Owner ChangeN/A
Market Cap12.57M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.97
P/S 1.03
P/FCF 10.26
P/OCF 10.26
P/B 5.33
P/tB N/A
EV/EBITDA 28.08
EPS(TTM)-0.25
EYN/A
EPS(NY)0.39
Fwd EY12.54%
FCF(TTM)0.3
FCFY9.75%
OCF(TTM)0.3
OCFY9.75%
SpS3.02
BVpS0.59
TBVpS-0.35
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.88%
ROE -39.96%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.33%
FCFM 10.07%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.02%
GM growth 5Y-3.92%
F-Score5
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 4.52
Debt/FCF 8.7
Debt/EBITDA 16.86
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion 193.68%
Profit Quality N/A
Current Ratio 2.28
Quick Ratio 2.12
Altman-Z 1.07
F-Score5
WACC6.94%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)12.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.68%
EPS Next Y97.22%
EPS Next 2Y74.8%
EPS Next 3Y63.58%
EPS Next 5YN/A
Revenue 1Y (TTM)-14.1%
Revenue growth 3Y26.49%
Revenue growth 5Y23.8%
Sales Q2Q%-9.38%
Revenue Next Year30.53%
Revenue Next 2Y24.18%
Revenue Next 3Y22.33%
Revenue Next 5YN/A
EBIT growth 1Y56.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year60%
EBIT Next 3Y76.22%
EBIT Next 5YN/A
FCF growth 1Y157.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y554.07%
OCF growth 3YN/A
OCF growth 5YN/A